[Comparison of 50 mg and 900 mg/day acetylsalicylic acid for prevention of recurrence after percutaneous transluminal angioplasty of the lower extremities: results of the LARA study].
Ranke
C
C
Abteilungen Angiologie, Medizinischen Hochschule Hannover.
Creutzig
A
A
Luska
G
G
Wagner
H H
HH
Galanski
M
M
Frölich
J C
JC
Avenarius
H J
HJ
Hecker
H
H
Alexander
K
K
D000368:Aged; D000800:Angioplasty, Balloon; D001157:Arterial Occlusive Diseases / Q000000981:diagnostic imaging / Q000628:therapy*; D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007511:Ischemia / Q000000981:diagnostic imaging / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011859:Radiography; D012008:Recurrence
D001241:Aspirin
Vergleich von 50 mg und 900 mg/Tag Acetylsalicylsäure zur Rezidiv-prophylaxe nach perkutaner transluminaler Angioplastie (PTA) der unteren Extremitäten: Ergebnisse der LARA-Studie.